Resources

Selected
  • RSV
  • RSV (Respiratory syncytial virus)
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)

71 results found

2024 ∙ NACI

Statement on the prevention of respiratory syncytial virus disease in older adults

  • Recommendation
  • Americas
  • Canada
  • Older adults
  • RSV (Respiratory syncytial virus)
Download:
2024 ∙ ACIP

ACIP Evidence to Recommendations for Use of Protein Subunit RSV vaccines (GSK Arexvy or Pfizer Abrysvo) in All Adults Aged ≥75 years and in Adults Aged 60–74 at Increased Risk of Severe RSV Disease

  • Background paper
  • Americas
  • United States of America
  • EtR framework
  • RSV (Respiratory syncytial virus)
Download:
2024 ∙ ACIP

ACIP Evidence to Recommendations for Use of Moderna RSV Vaccine (mResvia) in All Adults Aged ≥75 years and in Adults Aged 60–74 at Increased Risk of Severe RSV Disease

  • Background paper
  • Americas
  • United States of America
  • EtR framework
  • RSV (Respiratory syncytial virus)
Download:
2024 ∙ NIAC

recommendations for the passive immunisation of infants against Respiratory Synctytal Virus (RSV) during the 2024/2025 season

  • Recommendation
  • Europe
  • Ireland
  • RSV (Respiratory syncytial virus)
Download:
2024 ∙ NACI

Statement on the prevention of respiratory syncytial virus (RSV) disease in infants: Supplementary systematic review of economic evidence

  • Background paper
  • Americas
  • Canada
  • RSV (Respiratory syncytial virus)
Download:
2024 ∙ NACI

Statement on the prevention of respiratory syncytial virus (RSV) disease in infants

  • Recommendation
  • Americas
  • Canada
  • Newborn
  • RSV (Respiratory syncytial virus)
Download:
2024 ∙ ATAGI

ATAGI statement on Nirsevimab for the prevention of severe disease due to respiratory syncytial virus (RSV) in infants

  • Recommendation
  • Western Pacific
  • Australia
  • Children
  • RSV (Respiratory syncytial virus)
Download:
2023 ∙ Wittenauer, Rachel Pecenka, Clint Baral, Ranju

Cost of childhood RSV management and cost-effectiveness of RSV interventions: a systematic review from a low- and middle-income country perspective

  • Newborn
  • Children
  • Pregnant women
  • Low and Middle Income Countries
  • RSV (Respiratory syncytial virus)
  • Economic aspects
Methodological quality (AMSTAR 2):
Not applicable
2023 ∙ Ma, J. Chen, L. Tang, S. Shi, Y.

Efficacy and safety of respiratory syncytial virus vaccination during pregnancy to prevent lower respiratory tract illness in newborns and infants: a systematic review and meta-analysis of randomized controlled trials

  • Pregnant women
  • RSV (Respiratory syncytial virus)
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Low
2023 ∙ CAVEI

CAVEI recommendation on incorporation of a monoclonal antibody for passive immunization against respiratory syncytial virus in infants in the Program National Immunization

  • Recommendation
  • Americas
  • Chile
  • RSV (Respiratory syncytial virus)
Download:
Loading...